Formoterol: Pharmacology, molecular basis of agonism, and mechanism of long duration of a highly potent and selective β2-adrenoceptor agonist bronchodilator
- 31 December 1993
- journal article
- review article
- Published by Elsevier in Life Sciences
- Vol. 52 (26) , 2145-2160
- https://doi.org/10.1016/0024-3205(93)90729-m
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- FormoterolDrugs, 1991
- Inhaled formoterol inhibits histamine-induced airflow obstruction and airway microvascular leakageEuropean Journal of Pharmacology, 1991
- Inhibition of anti‐IgE induced skin response in normals by formoterol, a new β2 adrenoceptor agonist, and terbutalineAllergy, 1990
- Formoterol fumarate, a new β2‐adrenoceptor agonistAllergy, 1989
- Possible molecular basis for the pharmacokinetics and pharmacodynamics of three membrane-active drugs: Propranolol, nimodipine and amiodarone+Journal of Molecular and Cellular Cardiology, 1988
- Anti‐Allergic Activity of Formoterol, a New Beta‐Adrenoceptor Stimulant, and Salbutamol in Human Leukocytes and Human Lung TissueAllergy, 1983
- Comparison of Functional β-Adrenoceptor Heterogeneity in Central and Peripheral Airway Smooth Muscle of Guinea Pig and ManJournal of Receptor Research, 1983
- Effects of N-aralkyl substitution of β-agonists on α- and β-adrenoceptor subtypes: pharmacological studies and binding assaysJournal of Pharmacy and Pharmacology, 1982
- Salbutamol: agonistic and antagonistic activity at β-adrenoceptor sitesJournal of Pharmacy and Pharmacology, 1973
- Inhibition by Sympathomimetic Amines of Histamine Release induced by Antigen in Passively Sensitized Human LungNature, 1969